• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症 COVID-19 中肺单核细胞 - 巨噬细胞激活过程中 PPARγ 顺式作用元件组蛋白修饰的抑制作用

PPARγ Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.

作者信息

Desterke Christophe, Turhan Ali G, Bennaceur-Griscelli Annelise, Griscelli Frank

机构信息

INSERM UA9- University Paris-Saclay, Institut André Lwoff, Bâtiment A CNRS, 7 rue Guy Moquet, 94800 Villejuif, France.

ESTeam Paris Sud, INGESTEM National IPSC Infrastructure, University Paris-Saclay, 94800 Villejuif, France.

出版信息

iScience. 2020 Oct 23;23(10):101611. doi: 10.1016/j.isci.2020.101611. Epub 2020 Sep 25.

DOI:10.1016/j.isci.2020.101611
PMID:33015591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7518203/
Abstract

The molecular mechanisms of cytokine storm in patients with severe COVID-19 infections are poorly understood. To uncover these events, we performed transcriptome analyses of lung biopsies from patients with COVID-19, revealing a gene enrichment pattern similar to that of PPARγ-knockout macrophages. Single-cell gene expression analysis of bronchoalveolar lavage fluids revealed a characteristic trajectory of PPARγ-related disturbance in the CD14+/CD16+ cells. We identified a correlation with the disease severity and the reduced expression of several members of the PPARγ complex such as EP300, RXRA, RARA, SUMO1, NR3C1, and CCDC88A. ChIP-seq analyses confirmed repression of the PPARγ-RXRA-NR3C1 cistrome in COVID-19 lung samples. Further analysis of protein-protein networks highlighted an interaction between the PPARγ-associated protein SUMO1 and a nucleoprotein of the SARS virus. Overall, these results demonstrate for the first time the involvement of the PPARγ complex in severe COVID-19 lung disease and suggest strongly its role in the major monocyte/macrophage-mediated inflammatory storm.

摘要

严重新型冠状病毒肺炎(COVID-19)感染患者细胞因子风暴的分子机制目前尚不清楚。为了揭示这些情况,我们对COVID-19患者的肺活检组织进行了转录组分析,发现了一种与PPARγ基因敲除巨噬细胞相似的基因富集模式。对支气管肺泡灌洗液的单细胞基因表达分析揭示了CD14+/CD16+细胞中PPARγ相关紊乱的特征轨迹。我们发现疾病严重程度与PPARγ复合物的几个成员(如EP300、RXRA、RARA、SUMO1、NR3C1和CCDC88A)表达降低之间存在相关性。染色质免疫沉淀测序(ChIP-seq)分析证实了COVID-19肺样本中PPARγ-RXRA-NR3C1顺反子组被抑制。对蛋白质-蛋白质网络的进一步分析突出了PPARγ相关蛋白SUMO1与严重急性呼吸综合征(SARS)病毒核蛋白之间的相互作用。总体而言,这些结果首次证明了PPARγ复合物参与了严重的COVID-19肺部疾病,并有力地表明了其在主要单核细胞/巨噬细胞介导的炎症风暴中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/047fe023d0ef/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/4261e09f63f7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/132cc536268d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/3bb7e3e51258/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/158279a48e7b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/cfdfdd3c02c7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/9cf0f7eed6f9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/c7685934fe45/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/32200c72e722/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/047fe023d0ef/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/4261e09f63f7/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/132cc536268d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/3bb7e3e51258/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/158279a48e7b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/cfdfdd3c02c7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/9cf0f7eed6f9/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/c7685934fe45/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/32200c72e722/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/576b/7553361/047fe023d0ef/gr8.jpg

相似文献

1
PPARγ Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.重症 COVID-19 中肺单核细胞 - 巨噬细胞激活过程中 PPARγ 顺式作用元件组蛋白修饰的抑制作用
iScience. 2020 Oct 23;23(10):101611. doi: 10.1016/j.isci.2020.101611. Epub 2020 Sep 25.
2
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.单细胞转录组分析强调中性粒细胞和炎症性巨噬细胞在严重 COVID-19 发病机制中的作用。
Cells. 2020 Oct 29;9(11):2374. doi: 10.3390/cells9112374.
3
Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.新型冠状病毒-19(SARS-CoV-2)通过白细胞介素-1(IL-1)引起细胞因子风暴导致 COVID-19 的急性重症肺部炎症:一种有前途的抑制策略。
J Biol Regul Homeost Agents. 2020 Nov-Dec;34(6):1971-1975. doi: 10.23812/20-1-E.
4
Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.促炎细胞因子通过多种机制负调控人源和鼠源巨噬细胞中 PPARγ 介导的基因表达。
Immunobiology. 2013 Nov;218(11):1336-44. doi: 10.1016/j.imbio.2013.06.011. Epub 2013 Jul 1.
5
Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).过氧化物酶体增殖物激活受体γ(PPargamma)表达降低提示严重的肺结节病:γ干扰素(IFN-γ)可能参与其中。
Sarcoidosis Vasc Diffuse Lung Dis. 2006 Jun;23(2):93-100.
6
Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.单细胞转录组再分析显示 NR3C1-CXCL8-中性粒细胞轴决定了 COVID-19 的严重程度。
Front Immunol. 2020 Aug 28;11:2145. doi: 10.3389/fimmu.2020.02145. eCollection 2020.
7
Novel insight from the first lung transplant of a COVID-19 patient.首例 COVID-19 患者肺移植的新见解。
Eur J Clin Invest. 2021 Jan;51(1):e13443. doi: 10.1111/eci.13443. Epub 2020 Nov 20.
8
A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.一种STAT6抑制剂AS1517499通过抑制PPARγ降低凋亡细胞滴注对博来霉素诱导的肺纤维化的预防作用。
Cell Physiol Biochem. 2018;45(5):1863-1877. doi: 10.1159/000487877. Epub 2018 Feb 28.
9
Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.SARS-CoV-2 激活的肥大细胞释放组织胺,增加白细胞介素-1 水平,导致 COVID-19 中的细胞因子风暴和炎症反应。
J Biol Regul Homeost Agents. 2020;34(5):1629-1632. doi: 10.23812/20-2EDIT.
10
Differential TLR2 downstream signaling regulates lipid metabolism and cytokine production triggered by Mycobacterium bovis BCG infection.差异性TLR2下游信号传导调节牛分枝杆菌卡介苗感染引发的脂质代谢和细胞因子产生。
Biochim Biophys Acta. 2014 Jan;1841(1):97-107. doi: 10.1016/j.bbalip.2013.10.008. Epub 2013 Oct 10.

引用本文的文献

1
Paired single-cell and spatial transcriptional profiling reveals a central osteopontin macrophage response mediating tuberculous granuloma formation.配对的单细胞和空间转录谱分析揭示了一种介导结核性肉芽肿形成的核心骨桥蛋白巨噬细胞反应。
mBio. 2025 Aug 7:e0155925. doi: 10.1128/mbio.01559-25.
2
Role of innate immunity in SARS-CoV-2 infection.固有免疫在2019冠状病毒病感染中的作用。
Biosaf Health. 2023 Sep 9;5(5):280-288. doi: 10.1016/j.bsheal.2023.08.005. eCollection 2023 Oct.
3
The prognostic significance of insulin resistance in COVID-19: a review.

本文引用的文献

1
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
2
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19.COVID-19 患者支气管肺泡免疫细胞的单细胞景观。
Nat Med. 2020 Jun;26(6):842-844. doi: 10.1038/s41591-020-0901-9. Epub 2020 May 12.
3
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
胰岛素抵抗在2019冠状病毒病中的预后意义:综述
J Diabetes Metab Disord. 2024 Jan 20;23(1):305-322. doi: 10.1007/s40200-024-01385-8. eCollection 2024 Jun.
4
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy.过氧化物酶体增殖物激活受体在调节 SARS-CoV-2 感染引起的过度炎症反应中的作用:COVID-19 治疗的一个新视角。
Front Immunol. 2023 Feb 17;14:1127358. doi: 10.3389/fimmu.2023.1127358. eCollection 2023.
5
Identification of Transcriptome Biomarkers for Severe COVID-19 with Machine Learning Methods.利用机器学习方法鉴定严重 COVID-19 的转录组生物标志物。
Biomolecules. 2022 Nov 23;12(12):1735. doi: 10.3390/biom12121735.
6
Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19.单个支气管肺泡巨噬细胞的代谢建模揭示了新冠病毒感染中过度炎症的调节因子。
iScience. 2022 Oct 10;25(11):105319. doi: 10.1016/j.isci.2022.105319. eCollection 2022 Nov 18.
7
The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection.类胡萝卜素作为天然辅助治疗剂在预防冠状病毒感染方面的潜在健康益处的前景。
Biomed Pharmacother. 2022 Oct;154:113625. doi: 10.1016/j.biopha.2022.113625. Epub 2022 Aug 31.
8
Network pharmacology and molecular docking-based investigations of Kochiae Fructus's active phytomolecules, molecular targets, and pathways in treating COVID-19.基于网络药理学和分子对接的地肤子活性植物分子、分子靶点及治疗新型冠状病毒肺炎途径的研究
Front Microbiol. 2022 Aug 5;13:972576. doi: 10.3389/fmicb.2022.972576. eCollection 2022.
9
Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?高血糖、糖尿病并发症与 SARS-CoV-2 作用的人类蛋白的基因网络:共病的分子基础是什么?
Int J Mol Sci. 2022 Jun 29;23(13):7247. doi: 10.3390/ijms23137247.
10
A path-based analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2.基于通路的感染细胞系和COVID-19患者转录组分析揭示了针对SARS-CoV-2的新潜在靶点和药物。
Res Sq. 2022 Mar 21:rs.3.rs-1474136. doi: 10.21203/rs.3.rs-1474136/v1.
COVID-19 合并 2 型糖尿病患者的血糖控制与结局的相关性。
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3. doi: 10.1016/j.cmet.2020.04.021. Epub 2020 May 1.
4
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease.PPAR-γ 药理学(或合成)激动剂和营养激动剂作为 COVID-19 疾病细胞因子风暴调节的候选物。
Molecules. 2020 Apr 29;25(9):2076. doi: 10.3390/molecules25092076.
5
Effective treatment of severe COVID-19 patients with tocilizumab.托珠单抗治疗重症 COVID-19 患者有效。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975. doi: 10.1073/pnas.2005615117. Epub 2020 Apr 29.
6
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
7
Why tocilizumab could be an effective treatment for severe COVID-19?为什么托珠单抗可能是治疗严重 COVID-19 的有效方法?
J Transl Med. 2020 Apr 14;18(1):164. doi: 10.1186/s12967-020-02339-3.
8
High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)需要有创机械通气患者中肥胖的高患病率。
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199. doi: 10.1002/oby.22831. Epub 2020 Jun 10.
9
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.细胞因子(包括白细胞介素 6)在 COVID-19 诱导性肺炎和巨噬细胞活化综合征样疾病中的作用。
Autoimmun Rev. 2020 Jun;19(6):102537. doi: 10.1016/j.autrev.2020.102537. Epub 2020 Apr 3.
10
Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19).新型冠状病毒感染(COVID-19)无症状感染率的估计。
Int J Infect Dis. 2020 May;94:154-155. doi: 10.1016/j.ijid.2020.03.020. Epub 2020 Mar 14.